Km. Sekins et al., LONG-TERM PARTIAL LIQUID VENTILATION (PLV) WITH PERFLUBRON IN THE NEAR-TERM BABOON NEONATE, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1381-1387
Purpose: The feasibility and safety of continuous long-term (4-5 day)
partial liquid ventilation (PLV) using peflubron was demonstrated in n
ewborn baboons. PLV, a potential therapy for adult and neonatal respir
atory distress syndrome (RDS), is conventional mechanical ventilation
(CMV) with the lung filled to about functional residual capacity with
perfluorochemical liquid. Protocol: As a pilot trial for a larger prec
linical study focused on the safety of extended duration PLV, three ne
ar term baboons were studied. The animals were delivered by cesarean s
ection, anesthetized, intubated and placed on CMV. The animals were gi
ven intratracheal perflubron (30 ml/kg) and maintained on PLV for 96 h
ours. The transition back to gas ventilation occurred, after draining,
over the fifth day (hrs 96-120). Results: Two of the animals were bor
n with normal pulmonary function, while the third developed respirator
y distress prior to PLV. All the animals were adequately supported wit
h PLV using moderate ventilator settings and low concentrations of oxy
gen. Perflubron distribution was enhanced by periodic rotation of the
animals. Preliminary histology show vacuolated alveolar macrophages an
d no evidence of edema or other significant changes in the lungs. Pulm
onary function in the RDS animal, after PLV treatment, showed normal g
as exchange and lung mechanics. Conclusions: Three near term baboons,
one with clinical RDS, tolerated 4 days of PLV followed by 1 day of CM
V without complications using practical clinical management methods.